Problem

The Zyrtect team faced significant competition in a crowded marketplace where clinicians saw little differentiation between products. Their DTC programs were not providing a competitive advantage and they needed a new strategic approach

Solution

  • Working with the team’s agency of record and key cross functional participants, we convened a series of workshops and meetings to identify failures of the DTC approach and generate ideas to address them
  • We then conducted a series of research modules with patients to explore the clinical and emotional impacts of rhinitis to them.  This research incorporated a number of insight methodologies, such as feeling boards, acceptance validation, and laddering
  • We then led two additional creative workshops to incorporate the patient viewpoint
  • At the conclusion of the second workshop, we had developed a positioning platform and key messages in order to develop the creative brief for the agency to execute against.

Outcome

  • This project led to a completely revamped DTC campaign for the brand, focused on the wider range of allergens Zyrtec is approved for
  • Supported by a $40 million media spend, the campaign was credited with a 8% increase the brand year over year, with an estimated ROI of over $90 million